Evidence map›Paper›PMID 39574930›Full record

ReviewRSC advances2024

MXenes and artificial intelligence: fostering advancements in synthesis techniques and breakthroughs in applications.

Siavash Iravani, Arezoo Khosravi, Ehsan Nazarzadeh Zare, Rajender S Varma, Ali Zarrabi, Pooyan Makvandi

Abstract readReview
In one paragraph

Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Siavash IravaniIndependent Researcher W Nazar ST, Boostan Ave Isfahan Iran siavashira@gmail.com.ORCID https://orcid.org/0000-0003-3985-7928
Arezoo KhosraviDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Istanbul Okan University Istanbul 34959 Turkiye.
Ehsan Nazarzadeh ZareSchool of Chemistry, Damghan University Damghan 36716-45667 Iran.ORCID https://orcid.org/0000-0002-0446-4385
Rajender S VarmaCentre of Excellence for Research in Sustainable Chemistry, Department of Chemistry, Federal University of São Carlos 13565-905 São Carlos SP Brazil.ORCID https://orcid.org/0000-0001-9731-6228
Ali ZarrabiDepartment of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Istinye University Istanbul Turkiye alizarrabi@gmail.com.ORCID https://orcid.org/0000-0003-0391-1769
Pooyan MakvandiThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital 324000 Quzhou Zhejiang China pooyanmakvandi@gmail.com.ORCID https://orcid.org/0000-0003-2456-0961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review explores the synergistic relationship between MXenes and artificial intelligence (AI), highlighting recent advancements in predicting and optimizing the properties, synthesis routes, and diverse applications of MXenes and their composites. MXenes possess fascinating characteristics that position them as promising candidates for a variety of technological applications, including energy storage, sensors/detectors, actuators, catalysis, and neuromorphic systems. The integration of AI methodologies provides a robust toolkit to tackle the complexities inherent in MXene research, facilitating property predictions and innovative applications. We discuss the challenges associated with the predictive capabilities for novel properties of MXenes and emphasize the necessity for sophisticated AI models to unravel the intricate relationships between structural features and material behaviors. Moreover, we examine the optimization of synthesis routes for MXenes through AI-driven approaches, underscoring the potential for streamlining and enhancing synthesis processes

Identifiers

PMID39574930
PMCPMC11580157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.